Virginia Retirement Systems Et Al Ocular Therapeutix, Inc Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 16, 2023
SELL
$4.09 - $6.5 $218,815 - $347,750
-53,500 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$4.83 - $7.35 $102,879 - $156,555
21,300 Added 66.15%
53,500 $265,000
Q4 2021

Feb 03, 2022
BUY
$6.16 - $12.07 $134,288 - $263,126
21,800 Added 209.62%
32,200 $224,000
Q3 2021

Oct 21, 2021
BUY
$9.7 - $14.34 $100,879 - $149,136
10,400 New
10,400 $104,000

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $705M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email